Oric Pharmaceuticals Inc. buy BiotechBee
Start price
26.06.23
/
60%
€7.70
Target price
31.12.25
€9.00
Performance (%)
11.04%
Price
06.09.24
€8.65
Summary
This prediction is currently active. The BUY prediction by BiotechBee currently has a performance of 11.04%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Oric Pharmaceuticals Inc. | -4.945% | -4.945% | 6.790% |
iShares Core DAX® | -3.429% | 3.133% | 15.455% |
iShares Nasdaq 100 | -6.121% | -1.433% | 16.794% |
iShares Nikkei 225® | -7.364% | 1.018% | 8.293% |
iShares S&P 500 | -4.366% | 0.247% | 18.541% |
According to BiotechBee what are the pros and cons of Oric Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Oric Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 9,0
Stopped prediction by BiotechBee for Oric Pharmaceuticals Inc.
Oric Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.20
20.01.23
20.01.23
€8.00
30.04.25
30.04.25
-27.74%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year